Fecal Microbiota Transplantation | Estateplanning | Vibepedia.Network

Fecal microbiota transplantation (FMT), also known as stool transplantation, is a medical procedure that involves transferring fecal bacteria and other microbes from a healthy individual into an unhealthy individual, primarily to treat Clostridioides difficile infection (CDI). With a success rate of over 90% in treating recurrent CDI, FMT is gaining prominence as a potential first-line therapy. The process involves screening donors for pathogens, and the transplanted microbes can restore the balance of the gut microbiome, leading to improved health outcomes. FMT has been used experimentally to treat various gastrointestinal diseases, including colitis, constipation, and irritable bowel syndrome, as well as neurological conditions like multiple sclerosis and Parkinson's. As of 2013, the US FDA regulates human feces as an experimental drug, and the UK's Medicines and Healthcare products Regulatory Agency oversees FMT regulation. With over 500 clinical trials currently underway, FMT is poised to revolutionize the treatment of gut-related diseases, with a projected market size of $1.5 billion by 2025.